Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $187,221 - $559,266
5,100 Added 137.84%
8,800 $341,000
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $49,336 - $65,940
-1,400 Reduced 27.45%
3,700 $138,000
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $1.44 Million - $1.58 Million
-35,100 Reduced 87.31%
5,100 $226,000
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $852,768 - $1.01 Million
-22,400 Reduced 35.78%
40,200 $1.71 Million
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $2.05 Million - $2.28 Million
49,700 Added 385.27%
62,600 $2.72 Million
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $427,635 - $541,413
12,900 New
12,900 $464,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.